Tag: Prevention

Exploring new recommendations for doxyPEP

You may have heard of doxyPEP, which stands for doxycycline post-exposure prophylaxis. It involves taking an antibiotic called doxycycline after having sex without a condom. This can help prevent certain bacterial sexually transmitted infections (STIs), such as chlamydia, syphilis and possibly gonorrhea. This prevention strategy is relatively new but has been gaining attention across the country as another way to help reduce high rates of STIs. Although interest in using doxyPEP is growing, there is no global standard for its use. This prompted the Public Health Agency of Canada (PHAC) to publish recommendations that give health professionals evidence-based advice to...

Read more

DoxyPEP and antibiotic resistance: What have we learned so far?

Studies have found that the antibiotic doxycycline, when taken after sexual exposure, can significantly reduce the risk of some bacterial sexually transmitted infections like chlamydia and syphilis. However, it is generally less effective at reducing the risk of gonorrhea. Some researchers are concerned that over the long term, widespread use of doxycycline as post-exposure prophylaxis (doxyPEP) may diminish the antibiotic’s effectiveness, or even weaken the efficacy of some other antibiotics. Is this concern realistic? And if so, are the benefits worth the risk? Clinical trials The initial clinical trial of doxyPEP in San Francisco and Seattle found low rates of...

Read more

Doxy-PEP for syphilis prevention: What is it, does it work and how can we overcome barriers to access?

For years, gay, bisexual, trans, Two-Spirit and queer (GBT2Q) communities have been experiencing unacceptably high rates of syphilis with limited action taken by others outside the work of community-based sexual health organizations. However, provincial and federal responses have been stoked due to an increase in heterosexual transmission and a rise in cases of babies born with syphilis, also known as congenital syphilis. When acquired by a fetus during pregnancy, syphilis can result in miscarriage, stillbirth or permanent disability of the newborn. Consequently, efforts to leverage innovative syphilis interventions have accelerated, alongside interest in new prevention options for GBT2Q men. One...

Read more

Three reasons why CATIE supports U=U for sexual transmission

CATIE recently endorsed the Consensus Statement of the Prevention Access Campaign, celebrating the fact that “undetectable equals untransmittable.” This revolutionary statement, pushed forward by a dedicated group of people living with HIV, has prompted CATIE to reflect on our sexual HIV prevention messaging. The research on treatment as prevention has been slowly accumulating for many years. As an evidence-based organization, CATIE now recognizes that the evidence on undetectable viral load has reached a point where we are compelled to take our messaging a step further. We can comfortably say that when a person taking antiretroviral treatment has an ongoing undetectable...

Read more

Undetectable=Untransmittable – CATIE signs on

All of us here at CATIE, and indeed around the world, are celebrating the most significant development in the HIV world since the advent of effective combination therapy 20 years ago – people living with HIV with sustained undetectable viral loads can confidently declare to their sexual partners “I’m not infectious!” The “fabulousness” of this news cannot be overstated. With or without a condom, if you’re undetectable you won’t pass along HIV! This is an absolute game-changer and those who live with HIV can proudly share this information. At the same time, service providers working in HIV must get up...

Read more